Neurocrine Biosciences (NBIX) shares outstanding

Shares outstanding · fiscal 2025
102.50M

Neurocrine Biosciences (NBIX) had 102.50M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 1.2% lower than the 103.70M of fiscal 2024. Figures as of 18 Nov 2026, 12:41 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
102.50M
Change on fiscal 2024
−1.2%
Growth, 5 years
+0.9% a year
Growth, 10 years
+2.0% a year
Highest on record
103.70Mfiscal 2024
Lowest on record
39.14Mfiscal 2009
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Neurocrine Biosciences shares outstanding, in more detail

The market data feed counts 101.22M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 0.9% a year; over ten years the rate was 2.0% a year. Across the 17 fiscal years on record (2009–2025), the highest was 103.70M in fiscal 2024 and the lowest 39.14M in fiscal 2009.

History · 17 fiscal years

Shares outstanding by fiscal year

Neurocrine Biosciences shares outstanding, year by year

Neurocrine Biosciences (NBIX) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2025102.50M 1.2% down
2024103.70M 2.7% up
2023101.00M 2.1% up
202298.90M 1.0% up
202197.90M 0.1% up
202097.80M 2.2% up
201995.70M 0.3% up
201895.40M 8.3% up
201788.09M 1.6% up
201686.71M 2.6% up
201584.50M 13.3% up
201474.58M 11.3% up
201366.99M 0.1% up
201266.95M 18.8% up
201156.35M 6.7% up
201052.82M 35.0% up
200939.14M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of Neurocrine Biosciences and comparable companies
CompanyShares outstandingFiscal year
Revvity RVTY116.60M2025
Exelixis EXEL281.86M2025
Charles River Laboratories International CRL49.56M2025
Neurocrine Biosciences NBIX102.50M2025
Ascendis Pharma ASND60.61M2025
ICON ICLR79.09M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on NBIX

Neurocrine Biosciences, figure by figure

Neurocrine Biosciences (NBIX) overview: price, valuation and scorecardAll health care companies by market value

Neurocrine Biosciences shares outstanding: questions and answers

How many shares does Neurocrine Biosciences have?

Neurocrine Biosciences (NBIX) had 102.50M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 1.2% lower than the 103.70M of fiscal 2024. The market data feed counts 101.22M shares outstanding today.

What is the growth rate of Neurocrine Biosciences's diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 0.9% a year; over ten years the rate was 2.0% a year.

What are the highest and lowest diluted share count figures on record for Neurocrine Biosciences?

Across the 17 fiscal years on record (2009–2025), the highest was 103.70M in fiscal 2024 and the lowest 39.14M in fiscal 2009.

How is Neurocrine Biosciences's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Neurocrine Biosciences it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Neurocrine Biosciences (NBIX) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/NBIX/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.